title: Growth attenuation by commission and omission may be ethically justifiable in children with profound disabilities.
authors.forename: Lainie Friedman
authors.initials: LF
authors.lastname: Ross
mesh_terms: D002648:Child; D019988:Children with Disabilities; D004992:Ethics, Medical; D006128:Growth / Q000187:drug effects*; D013006:Growth Hormone / Q000008:administration & dosage; D006801:Humans
chemical_list: D013006:Growth Hormone